78 related articles for article (PubMed ID: 2215514)
1. Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma: cytotoxicity, growth kinetics and phenotype.
Lotzová E; Savary CA; Freedman RS; Edwards CL; Morris M
Cancer Immunol Immunother; 1990; 31(3):169-75. PubMed ID: 2337905
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression.
Parkhurst MR; Riley JP; Dudley ME; Rosenberg SA
Clin Cancer Res; 2011 Oct; 17(19):6287-97. PubMed ID: 21844012
[TBL] [Abstract][Full Text] [Related]
3. Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine.
Quixabeira DCA; Jirovec E; Pakola S; Havunen R; Basnet S; Santos JM; Kudling TV; Clubb JHA; Haybout L; Arias V; Grönberg-Vähä-Koskela S; Cervera-Carrascon V; Pasanen A; Anttila M; Tapper J; Kanerva A; Hemminki A
Cancer Gene Ther; 2023 Nov; 30(11):1543-1553. PubMed ID: 37666898
[TBL] [Abstract][Full Text] [Related]
4. IL-2 and Beyond in Cancer Immunotherapy.
Wrangle JM; Patterson A; Johnson CB; Neitzke DJ; Mehrotra S; Denlinger CE; Paulos CM; Li Z; Cole DJ; Rubinstein MP
J Interferon Cytokine Res; 2018 Feb; 38(2):45-68. PubMed ID: 29443657
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Infiltrating iNKT Cells Activated through c-Kit/Sca-1 Are Induced by Pentoxifylline, Norcantharidin, and Their Mixtures for Killing Murine Melanoma Cells.
Correa-Lara MVM; Lara-Vega I; Nájera-Martínez M; Domínguez-López ML; Reyes-Maldonado E; Vega-López A
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895943
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches.
Alam F; Islam MA; Khalil MI; Gan SH
Curr Pharm Des; 2016; 22(20):3034-49. PubMed ID: 26951104
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer.
Cui C; Tian X; Wu J; Zhang C; Tan Q; Guan X; Dong B; Zhao M; Lu Z; Hao C
Cancer Sci; 2019 Jan; 110(1):61-71. PubMed ID: 30426614
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Sequencing of T Cell Receptors.
Bai X; Zhang Q; Wu S; Zhang X; Wang M; He F; Wei T; Yang J; Lou Y; Cai Z; Liang T
Sci Rep; 2015 Sep; 5():13664. PubMed ID: 26329277
[TBL] [Abstract][Full Text] [Related]
9. Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas.
Halapi E; Yamamoto Y; Juhlin C; Jeddi-Tehrani M; Grunewald J; Andersson R; Hising C; Masucci G; Mellstedt H; Kiessling R
Cancer Immunol Immunother; 1993; 36(3):191-7. PubMed ID: 8439980
[TBL] [Abstract][Full Text] [Related]
10. Role of natural killer cells in cancer.
Pross HF; Lotzová E
Nat Immun; 1993; 12(4-5):279-92. PubMed ID: 8257832
[TBL] [Abstract][Full Text] [Related]
11. Cell therapy: achievements and perspectives.
Bordignon C; Carlo-Stella C; Colombo MP; De Vincentiis A; Lanata L; Lemoli RM; Locatelli F; Olivieri A; Rondelli D; Zanon P; Tura S
Haematologica; 1999 Dec; 84(12):1110-49. PubMed ID: 10586214
[TBL] [Abstract][Full Text] [Related]
12. Role of human circulating and tumor-infiltrating lymphocytes in cancer defense and treatment.
Lotzová E
Nat Immun Cell Growth Regul; 1990; 9(4):253-64. PubMed ID: 2215514
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
[TBL] [Abstract][Full Text] [Related]
14. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.
Heo DS; Whiteside TL; Kanbour A; Herberman RB
J Immunol; 1988 Jun; 140(11):4042-9. PubMed ID: 3286766
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
